Jane Street
APLS

Jane Street’s Apellis Pharmaceuticals APLS Stock Holding History

Jane Street’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.48M Sell
210,900
-52,100
-20% -$1.12M ﹤0.01% 2749
2025
Q4 		$6.61M Sell
263,000
-38,500
-13% -$903K ﹤0.01% 2832
2025
Q3 		$6.82M Buy
301,500
+96,000
+47% +$2.24M ﹤0.01% 2953
2025
Q2 		$3.56M Buy
205,500
+108,100
+111% +$2M ﹤0.01% 3489
2025
Q1 		$2.13M Sell
97,400
-99,800
-51% -$2.76M ﹤0.01% 4253
2024
Q4 		$6.29M Sell
197,200
-283,800
-59% -$8.53M ﹤0.01% 2377
2024
Q3 		$13.9M Buy
481,000
+25,000
+5% +$926K ﹤0.01% 1585
2024
Q2 		$17.5M Buy
456,000
+154,700
+51% +$7.01M ﹤0.01% 1445
2024
Q1 		$17.7M Sell
301,300
-727,700
-71% -$46.4M ﹤0.01% 1297
2023
Q4 		$61.6M Buy
1,029,000
+149,500
+17% +$7.58M 0.02% 586
2023
Q3 		$33.5M Buy
879,500
+696,800
+381% +$30.6M 0.01% 752
2023
Q2 		$16.6M Sell
182,700
-76,500
-30% -$6.6M 0.01% 1395
2023
Q1 		$17.1M Sell
259,200
-69,500
-21% -$4.01M 0.01% 1112
2022
Q4 		$17M Sell
328,700
-25,900
-7% -$1.37M 0.01% 1126
2022
Q3 		$24.2M Buy
354,600
+206,100
+139% +$12.2M 0.01% 918
2022
Q2 		$6.71M Buy
148,500
+24,100
+19% +$1.1M ﹤0.01% 2240
2022
Q1 		$6.32M Buy
124,400
+85,500
+220% +$3.77M ﹤0.01% 2649
2021
Q4 		$1.84M Sell
38,900
-228,700
-85% -$9M ﹤0.01% 4644
2021
Q3 		$8.82M Buy
267,600
+176,600
+194% +$9.92M ﹤0.01% 1962
2021
Q2 		$5.75M Buy
91,000
+29,200
+47% +$1.51M ﹤0.01% 2431
2021
Q1 		$2.65M Buy
61,800
+15,200
+33% +$719K ﹤0.01% 3494
2020
Q4 		$2.67M Buy
+46,600
New +$1.97M ﹤0.01% 2996
2020
Q3 		– Sell
-34,200
Closed -$1.12M – 7106
2020
Q2 		$1.12M Buy
+34,200
New +$1.1M ﹤0.01% 3901

Other funds holding APLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Jane Street's APLS Position: Q1 2026 in Review

Jane Street sold out of Apellis Pharmaceuticals (APLS) in Q1 2026, closing a stake of 50,114 shares — an estimated $1.08M sold.

Jane Street first reported a position in APLS in Q2 2019 and held it in 26 quarters. The position peaked at $43.8M in Q2 2023. 321 funds tracked by Wall St. Rank hold APLS as of Q1 2026.

  • Jane Street reported no remaining Apellis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 50,114 Apellis Pharmaceuticals shares in Q1 2026, an estimated $1.08M.
  • Jane Street first reported a position in Apellis Pharmaceuticals in Q2 2019 and held it in 26 quarters.
  • Jane Street's Apellis Pharmaceuticals position peaked at $43.8M in Q2 2023.
  • 321 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.